Quantum computing has moved from theoretical possibility to functional (if limited) reality. Understanding what quantum computers actually do — and what they don't do — cuts through the hype that has surrounded the field.
Classical computers use bits (0 or 1). Quantum computers use qubits, which exploit quantum mechanical properties: superposition (existing as 0 and 1 simultaneously until measured) and entanglement (correlating qubits so that the state of one instantly affects another regardless of distance). These properties allow quantum computers to explore many possible solutions simultaneously — but only for specific problem types.
Quantum advantage — where quantum computers outperform classical ones — exists for specific problem categories: factoring large numbers (Shor's algorithm, threatening current encryption), searching unsorted databases (Grover's algorithm), simulating quantum systems (chemistry, materials science, drug discovery), and certain optimization problems. General-purpose computation is not where quantum advantage lies. I'll admit this surprised me when I first looked into it.
IBM, Google, and IonQ are the leading quantum hardware providers. IBM's quantum systems have reached hundreds of qubits, but qubit quality (coherence time and error rates) remains the primary limitation. Error correction requires many physical qubits per logical qubit — scaling to fault-tolerant quantum computation requires hardware progress beyond current capabilities. "Quantum supremacy" demonstrations show quantum advantage for artificial tasks; practical advantage for commercially relevant problems remains ahead.
Here's where I land on this: The findings will update as we learn more. The method stays sound.
The major quantum computing approaches differ in their qubit implementations: superconducting qubits (IBM, Google) operate at near absolute zero and lead in qubit count; trapped ion qubits (IonQ, Quantinuum) have lower error rates but scale more slowly; photonic qubits operate at room temperature but require different manufacturing. Each approach has different error rate, connectivity, and scalability characteristics that make comparing qubit counts across systems misleading — a 100-qubit trapped ion system may outperform a 1,000-qubit superconducting system on certain problems.
The applications most likely to benefit from near-term quantum advantage are quantum chemistry simulations for drug discovery and materials science, certain optimization problems in logistics and finance, and quantum machine learning for specific problem types. These applications exploit quantum systems' natural ability to represent quantum states in ways that classical simulation requires exponentially more resources to replicate. The timelines for these applications are measured in years, not decades, but the specific problems where quantum provides clear advantage over the best classical algorithms are more limited than general coverage suggests.
From experience: Examining peer-reviewed literature alongside popular science coverage consistently reveals a gap: actual findings are more nuanced — and usually more interesting — than the headlines suggest.
The National Academies of Sciences, Engineering, and Medicine distinguishes between scientific consensus (established through replication across independent research groups) and emerging findings (preliminary results from limited studies) — a distinction that popular science coverage frequently collapses in ways that mislead readers about the actual state of evidence.
Honest Bottom Line: Quantum computing hardware approaches (superconducting, trapped ion, photonic) differ in error rates and scalability — qubit count comparisons across systems are misleading. Near-term quantum advantage is most likely in quantum chemistry simulation for drug discovery and specific optimization problems. Full fault-tolerant quantum computing enabling broader applications remains 5-15 years away; the specific problems with clear quantum advantage are currently more limited than general coverage suggests.

Alex Nguyen holds a PhD in Biochemistry and has spent 8 years translating cutting-edge scientific research for general audiences. He covers biology, physics, climate science, and emerging research with the commitment to ...